Efficacy of Margetuximab vs Trastuzumab in Patients With Pretreated ERBB2-Positive Advanced Breast Cancer
1. 系统已在2025-07-18 11:58:02对应助文件进行删除
2. 如有需要请重新发布求助信息
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: 10.1001/jamaoncol.2020.7932
文献链接: https://jamanetwork.com/journals/jamaoncology/fullarticle/2775599
其他信息:
出版社: American Medical Association (AMA)
作者: Hope S. Rugo; Seock-Ah Im; Fatima Cardoso; Javier Cortés; Giuseppe Curigliano; Antonino Musolino; Mark D. Pegram; Gail S. Wright; Cristina Saura; Santiago Escrivá-de-Romaní; Michelino De Laurentiis; Christelle Levy; Ursa Brown-Glaberman; Jean-Marc Ferrero; Maaike de Boer; Sung-Bae Kim; Katarína Petráková; Denise A. Yardley; Orit Freedman; Erik H. Jakobsen; Bella Kaufman; Rinat Yerushalmi; Peter A. Fasching; Jeffrey L. Nordstrom; Ezio Bonvini; Scott Koenig; Sutton Edlich; Shengyan Hong; Edwin P. Rock; William J. Gradishar; undefined undefined